date,title,source
Nov-07-18,"Aridis Pharmaceuticals Announces Publication of Positive AR-301 Phase 1/2a Data in ""Intensive Care Medicine"" and ""The Lancet Respiratory Medicine""",PR Newswire
Nov-13-18,Aridis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Corporate Overview,PR Newswire
Nov-21-18,"Analysis: Positioning to Benefit within The ONE Group Hospitality, Biofrontera AG Sponsored ADR, Aridis Pharmaceuticals, Universal Logistics, Tonix Pharmaceuticals Holding, and AVROBIO  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
